Tag: Crohn’s Disease
Perianal Fistulizing Complications Preventable in Crohn Disease
Steroid-sparing therapy may reduce risk for PFCs in young patients with Crohn disease
Early Deep Remission of Crohn Disease Tied to Better Outcomes
Findings show significant decrease in adverse outcomes over three years of follow-up
Low-FODMAP Diet Relieves Gut Symptoms for More IBD Patients
Adequate relief of gut symptoms reported for more patients following low-FODMAP versus control diet
Risk for Developing Idiopathic Pulmonary Fibrosis Up in IBD
Incidence of IPF significantly higher in patients with Crohn disease than in controls
Infliximab Introduction Has Not Cut IBD-Related Hospitalizations
Introduction of infliximab did not lead to drop in hospitalization, intestinal resection, colectomy
Biomarker Test Predicts Mild, Serious IBD in Newly Diagnosed
Test based on genetic signature of CD8 T cells during active disease
In Men, Low BMI Tied to Later Inflammatory Bowel Disease
Risk lasts through 40 years of adulthood for underweight adolescent men
Older Patients With Crohn Disease May Benefit From Early Combo Tx
Early step-up combo therapy includes tumor necrosis factor-α antagonist plus an antimetabolite
Malnutrition Ups Risk of Postop Issues in Pediatric Crohn Disease
In propensity-matched analysis, mild, severe malnutrition linked to elevated odds of complications
Reference Infliximab, Biosimilar Equivalent for Crohn’s Disease
CT-P13 is equivalent to reference product in primary outcome; no difference in safety outcomes
